WHEB’s Performance Review of 2022

December proved a bruising month for equities. The US Federal Reserve stressed that interest rates were unlikely to fall over 2023, despite slowing inflation, and the European Central Bank warned markets not to expect an end to rate rises, even as the region is expected to slide into recession. As a result of these recessionary fears, defensive sectors fared better during the month.

The fund, which returned -5.9%, slightly underperformed the MSCI World Index, which returned -5.4%, over December. Resource Efficiency and Water Management were our worst performing themes over the month while Environmental Services and Safety were the best. The strategy was impacted by being underweight certain value and defensive sectors.

In our commentary, Fund Manager Ted Franks discusses the key events of 2022 and the implications of this challenging year on our strategy. He concludes that, despite the many current crosswinds and challenges, the need to address longer term sustainability issues has never been greater, and our companies are part of the solution.

In other news, WHEB signed the Finance for Biodiversity Pledge during COP15 calling on global leaders and committing to protect and restore biodiversity through their finance activities and investments. This pledge now represents 126 signatories from 21 countries with €18.8tn of assets under management.

Top Holdings (alphabetically)

Advanced Drainage Systems Inc

United States

Industrials

Advanced Drainage Systems is a leading provider of stormwater management systems in the US. It is the leading manufacturer of high performance thermoplastic corrugated pipe, providing a comprehensive suite of water management products and superior drainage solutions for use in the underground construction and infrastructure marketplace. The company's products are generally lighter, more durable, more cost effective and easier to install than comparable alternatives made with traditional materials.

Ansys

United States

Information Technology

Ansys is a market leader in multiphysics engineering simulation software for product design and optimisation. The company follows a strategy of Pervasive Engineering Simulation to enable innovation. Its software accelerates product time to market, improves engineering and optimises product quality and safety for a variety of products including fuel efficient cars and planes, wind turbines as well as medical technology and consumer products.

CSL

Australia

Health Care

CSL develops medical products for serious and life-threatening diseases. Its core business is as a provider of human blood plasma-derived products to treat bleeding disorders, rare and serious infections and autoimmune diseases. CSL also manufactures vaccines and related products, including for flu and cervical cancer, as well as other products that speed up recovery times for patients that have undergone heart surgery, organ transplants and burns. The company provides these solutions across North America, Europe, Asia, Australia as well as other parts of the world.

Danaher

United States

Health Care

Danaher is a diversified business that designs, manufactures and sells laboratory equipment and consumables to clinical and medical laboratories including microscopes, analytical software and imaging and molecular devices. These tools are used in the development of new drugs and for diagnosing critically ill patients. In addition, the company also designs, manufactures and sells equipment to test and treat water (incl. UV water treatment systems). Overall, Danaher's products offer improved efficiency and reliability.

Globus Medical Inc

United States

Health Care

Globus Medical is a best-in-class spinal medical technology company headquartered in Pennsylvania, US. It has a large portfolio of solutions to promote healing in patients with musculoskeletal disorders. A newer, fast growing segment called "Enabling Technologies" centres around ExcelsiusGPS, the world's first robotic navigation platform which supports surgeons in spinal operations. The company was founded in 2003.

Icon

United States

Health Care

ICON is a clinical research organisation (CRO) which provides outsourced development services on a global basis to the pharmaceutical, biotechnology and medical device industries. The company's mission is to accelerate the development of drugs and devices that save lives and improve the quality of life. ICON specialises in the strategic development, management and analysis of programmes to support all stages of the of the clinical development process.

Linde

United States

Materials

Linde Plc produces and distributes industrial gases. The company operates globally supplying oxygen, hydrogen and other gases to a very wide range of downstream markets including into manufacturing industries, petrochemical and electronics industries. The gases are used in a variety of applications including in making manufacturing processes more efficient and in reducing harmful emissions. The company is establishing a strong presence in the green hydrogen market and also sells oxygen and other gases into the healthcare sector.

Steris

United States

Health Care

Steris provides a variety of products and services to the healthcare industry including specifically to hospitals, medical device manufacturers, pharmaceutical and biotechnology businesses as well as for food safety and industrial markets. The company's main areas of activity are in providing hygiene, sterilisation and anti-microbial treatment services to these end markets in order to ensure a safe and hygienic operating environment.

Thermo Fisher Scientific

United States

Health Care

Thermo Fisher Scientific is one of the largest suppliers of analytical instrument, equipment, consumables and software for healthcare and environmental research, analysis, discovery and diagnostics. The company offers a very wide range of products and services including the equipment needed to analyse samples as well as the variety of containers and other consumables needed to handle them.

Trane Technologies PLC

United States

Industrials

Trane is a world leader in air conditioning systems and services. The company serves engineers, contractors and business owners across an array of markets including education, healthcare, government and manufacturing. It also provides climate-controlled transport solutions to the food and medical industries. It also has an offering in the heat pump space which brings a 300% efficiency gain compared with the system it would replace.

2022 was a challenging year for the global economy. Geopolitical tensions between liberal democracies and authoritarian states finally cracked. Russia’s invasion of Ukraine shocked observers and extracted a dreadful humanitarian toll. Xi Jinping’s consolidation of power in China accelerated a rethink of relations with that country. Two decades of uneasy but profitable openness came to an abrupt halt.

This rift is a challenging headwind in the fight for sustainability. In 2022 it also presented immediate economic challenges. Energy prices rose fiercely. The global supply chain buckled, raising input prices. Labour shortages emerged in many markets. Inflation shot to record levels, prompting rapid increases in interest rates from central banks.

Against this recessionary backdrop, global financial markets contracted.  The fund’s benchmark, the MSCI World Index of stocks, fell as much as 18.8% before recovering to end the year 12.2% down.

Underneath that headline move, there was a very marked style rotation between “growth” and “value” strategies. “Growth” companies justify their valuations on future prospects. With interest rates rising, the cost of waiting for those growing profits rose, and share prices consequently fell. Meanwhile, “value” companies that can point to near-term cash flow came into favour. The MSCI World Value Index (which ended flat) outperformed the MSCI World Growth Index by more than 24% in AUD over 2022.

There were also quite marked differences in performance from different sectors of the economy.  Higher energy prices buoyed energy producers, whether renewable or fossil. Otherwise, recessionary fears benefitted defensive sectors such as utilities, consumer staples and financials.

Sectors relying on consumer and business confidence, such as consumer discretionary and industrials, had a more difficult year. Some of the weakest performance was in the information and communication technology sectors, where growth expectations had been highest.

Smaller or mid-sized companies also underperformed their larger peers, for the 7th year out of 10.

The investment strategy’s natural biases are on the wrong side of many of these market moves. As an impact strategy, we tend towards companies with strong growth prospects. Our companies provide solutions to sustainability challenges, and the need for their products and services is growing rather than falling. We also favour “pure play” companies where we can find them, and it is unusual to find very large companies which are dedicated to sustainability solutions.

As a consequence, the fund struggled in 2022.  The Fund fell 21.7%, underperforming by 9.5%.

The largest proportion of that underperformance came from companies in our Resource Efficiency theme.  This is one of our two largest themes, along with Health. Many of the companies in this theme can be somewhat cyclical. They have good long term growth prospects, but any given year can be influenced by economic conditions. They tend to be either industrial or information technology companies.

In the face of falling business confidence, many of these companies struggled this year. They include: computer-aided design companies Autodesk and Ansys; semiconductor manufacturer Silicon Labs; and industrial efficiency companies including Spirax-Sarco, Keyence and Daifuku.

This last group also includes the worst contributing stock in the Resource Efficiency theme, Kion. Kion makes energy-efficient forklift trucks, but also has a warehouse automation division which we were particularly interested in. In the middle of the year it issued a major profit warning. The long-term contracts it had signed did not allow for the pass-through of increased input costs. This was contrary to what we had previously understood so we sold our position.

As our Resource Efficiency theme faced falling business confidence, so our next-weakest theme, Wellbeing, suffered from pressure on consumers. This was particularly felt by the worst-contributing stock in the theme, HelloFresh.

HelloFresh is the world’s leading meal kit delivery company. It provides a healthier alternative to ready-prepared food and is also helping to decarbonise the food supply chain. Despite relatively resilient operational and financial performance, HelloFresh’s shares were hit by fears over falling consumer spending. We continue to think that the company is well-placed for continued profitable growth.

The Wellbeing theme was also weakened by the poor performance of Orpea. Orpea is a care home operator, primarily across Europe. In the early part of the year, allegations emerged of poor quality care in one of its French divisions. Unfortunately these allegations, and more damagingly, management’s response to them, fell far below the standard we expect of our companies so we closed our position.

On the other side of the ledger, our best performing theme was Cleaner Energy.  FirstSolar, SolarEdge and Vestas in the theme all performed strongly. The war in Ukraine has further highlighted the need to move away from volatile and politically costly fossil fuels. A landmark piece of legislation from the US, the Inflation Reduction Act, also drove strong share price performance.

The Education theme was another positive contributor. Grand Canyon Education in that theme recovered strongly as student enrolment trends began to improve.

The remaining five themes were all smaller negative contributors. This includes our Health theme. Although we do have stocks in this theme with defensive characteristics, the more impactful and innovative healthcare names we invest in tend to be more growth-orientated. Fisher and Paykel and ICON were notable negative contributors in this theme.

We took advantage of the market volatility in the first part of the year, to invest in several companies we had been monitoring for a while.  This resulted in seven additions and eight exits in the first quarter of the year.

After those changes, the portfolio has remained largely consistent.  Given the new uncertainties in the global economy, we have been working hard to make sure our companies still represent compelling investment opportunities.  We are confident that they are.  Despite the many current crosswinds and challenges, the need to address longer term sustainability issues has never been greater, and our companies are part of the solution.